All Companies

BMY

Bristol-Myers Squibb Co.

Pharmaceutical Preparations

$63.1updated Jul 30, 2026

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Total Trades

17

Politicians Trading

10

Last Traded

Jun 16, 2026

Price history

Congressional Trades

PoliticianNotifiedTradedTypeAmountChange
Ro KhannaDJul 6, 2026Jun 16, 2026Sell$1,001 - $15,000+12.84%
Ro KhannaDJun 9, 2026May 15, 2026Buy$1,001 - $15,000+10.70%
Mike KellyRJun 11, 2026May 7, 2026Sell$15,001 - $50,000+12.18%
Alan ArmstrongRJul 21, 2026Mar 27, 2026Buy$1,001 - $15,000+7.79%
Gilbert Ray Cisneros, Jr.DJan 12, 2026Dec 19, 2025Buy$1,001 - $15,000+16.44%
Julie JohnsonDJan 15, 2026Dec 18, 2025Sell$1,001 - $15,000+18.32%
Julie JohnsonDDec 11, 2025Nov 13, 2025Sell$1,001 - $15,000+29.76%
Gilbert Ray Cisneros, Jr.DDec 15, 2025Nov 12, 2025Buy$1,001 - $15,000+28.57%
Gilbert Ray Cisneros, Jr.DNov 18, 2025Oct 9, 2025Sell$1,001 - $15,000+41.23%
Julie JohnsonDSep 11, 2025Aug 14, 2025Sell$1,001 - $15,000+31.98%
Virginia FoxxRJul 3, 2025Jun 24, 2025Sell$1,001 - $15,000+34.17%
Jefferson ShreveRJun 22, 2025May 12, 2025Sell$15,001 - $50,000+30.97%
Julia LetlowRJan 13, 2026Apr 28, 2025Sell$1,001 - $15,000+30.21%
Tommy TubervilleRMay 15, 2025Apr 15, 2025Sell$1,001 - $15,000+26.20%
Julie JohnsonDMay 14, 2025Apr 1, 2025Sell$1,001 - $15,000+5.96%
Greg LandsmanDApr 8, 2025Mar 27, 2025Sell$1,001 - $15,000+7.13%
Julie JohnsonDFeb 12, 2025Jan 15, 2025Buy$1,001 - $15,000+12.86%